Chagnac A - Search Results

1

Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

D'Agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M, Praga M. D'Agati VD, et al. Among authors: chagnac a. Nat Rev Nephrol. 2016 Aug;12(8):453-71. doi: 10.1038/nrneph.2016.75. Epub 2016 Jun 6. Nat Rev Nephrol. 2016. PMID: 27263398 Review.

2

Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity.

Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Chagnac A, et al. Nephron. 2019;143(1):38-42. doi: 10.1159/000499486. Epub 2019 Apr 4. Nephron. 2019. PMID: 30947190 Review.

3

Obesity-Related Glomerulopathy: Clinical Management.

Herman-Edelstein M, Weinstein T, Chagnac A. Herman-Edelstein M, et al. Among authors: chagnac a. Semin Nephrol. 2021 Jul;41(4):358-370. doi: 10.1016/j.semnephrol.2021.06.007. Semin Nephrol. 2021. PMID: 34715965 Review.

4

Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria.

Tobar A, Ori Y, Benchetrit S, Milo G, Herman-Edelstein M, Zingerman B, Lev N, Gafter U, Chagnac A. Tobar A, et al. Among authors: chagnac a. PLoS One. 2013 Sep 25;8(9):e75547. doi: 10.1371/journal.pone.0075547. eCollection 2013. PLoS One. 2013. PMID: 24086563 Free PMC article.

5

Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial.

Zingerman B, Herman-Edelstein M, Erman A, Bar Sheshet Itach S, Ori Y, Rozen-Zvi B, Gafter U, Chagnac A. Zingerman B, et al. Among authors: chagnac a. PLoS One. 2015 Sep 14;10(9):e0137163. doi: 10.1371/journal.pone.0137163. eCollection 2015. PLoS One. 2015. PMID: 26367377 Free PMC article. Clinical Trial.

6

Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.

Herman-Edelstein M, Chagnac A, Nevo Z, Skutelsky E, Evron Y, Hirsch Y, Ben-Dor L, Schwartz I, Schwartz D, Weinstein T. Herman-Edelstein M, et al. Among authors: chagnac a. Exp Toxicol Pathol. 2016 Nov;68(10):543-552. doi: 10.1016/j.etp.2016.08.004. Epub 2016 Aug 31. Exp Toxicol Pathol. 2016. PMID: 27591087

7

Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.

Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, Gafter U, Salman H. Ori Y, et al. Among authors: chagnac a. Nephrol Dial Transplant. 2013 Jul;28(7):1787-93. doi: 10.1093/ndt/gfs587. Epub 2013 Feb 1. Nephrol Dial Transplant. 2013. PMID: 23378418

8

The very old on hemodialysis: 8 years' experience in a single unit.

Zingerman B, Korzets A, Ori Y, Herman-Edelstein M, Rozen-Zvi B, Gafter U, Chagnac A. Zingerman B, et al. Among authors: chagnac a. Blood Purif. 2014;37(1):12-7. doi: 10.1159/000357016. Epub 2014 Jan 28. Blood Purif. 2014. PMID: 24481227

9

Association of obesity and muscle mass with risk of albuminuria in renal transplant recipients.

Zingerman B, Erman A, Mashraki T, Chagnac A, Rozen-Zvi B, Rahamimov R. Zingerman B, et al. Among authors: chagnac a. J Nephrol. 2021 Aug;34(4):1315-1325. doi: 10.1007/s40620-020-00883-1. Epub 2020 Oct 24. J Nephrol. 2021. PMID: 33098523

10

Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption.

Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J, Gafter U. Chagnac A, et al. Nephrol Dial Transplant. 2008 Dec;23(12):3946-52. doi: 10.1093/ndt/gfn379. Epub 2008 Jul 12. Nephrol Dial Transplant. 2008. PMID: 18622024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters